ArticleBritish journal of cancer2022

Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.

Maxine Umeh-Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.